Given that cis-pQTL did not support a role for SRP14 with leukaemia risk, it is therefore possible that SRP14, as a biomarker of imminent leukaemia diagnosis, may indicate constitutively active JAK2. This evidence concerns the gene JAK2 and leukemia.